On April 29, 2015, partner Jane E. Jablons spoke at the GTCbio Diabetes Summit 2015 in Boston, MA participating in the “Investment Opportunities in Diabetes and Metabolic Disorders” panel. Ms. Jablon’s participation focused on early-stage venture capital investment in medical devices and diagnostics and what VC investors are looking for in early stage companies.